Ann: Appendix 4C and Quarterly Activity Report, page-3

Agreed dunover, positive pointers except for negligible Evolis sales. We were led to believe almost a decade ago that US sales would reach $100m within 7 years.

Evolis should still be the main brand to promote given its unique hair care features and huge target global market.

Yet the incumbent management continues its flawed obsession on excess M&A. Question why the quest for in house M&A deals now apparently its default stock in trade with beauty products simply camouflage and AN1 as a mere play thing.

Wow, they’ve finally realised the need for a Director of Strategy……part time! The expectation for the grant of 1,000,000 options is a lift in sp to 6 cents.Hopefully that at least arrests the slide in sp having halved and halved again multiple times in recent years.